Glucose intolerance or an elevated serum concentration of insulin is thought to be a risk factor for the development of colorectal cancer. [1] [2] [3] [4] [5] [6] [7] This association is based on the hypothesis that hyperinsulinemia promotes colon carcinogenesis. 1 In vitro, insulin acts as a growth factor for colonic epithelial cells and a mitogen for tumor cell growth. 1 The incidence rates of glucose intolerance and diabetes mellitus are increasing in Japan, and this, together with increased fat intake and sedentary working conditions, may be associated with the recently observed increase in the incidence of colorectal cancer and death from this disease in Japan. However, no prospective epidemiological study of the association between these biomarkers and colon cancer risk has been performed in the general population in Japan.
To determine the association between glucose intolerance and colorectal cancer in Japan, we carried out a nested case-control study using stored sera from the Japan Collaborative Cohort Japan) at SRL laboratory (Hachioji, Japan), with those performing the measurement blinded to the case-control status of samples. The coefficient of variance was 0.5-0.8% for glycoalbumin. Fasting status at the time of blood donation was not recorded.
The difference in means between cases and controls was examined by t-test, and that in proportion was examined by chi-square test. The risk of colorectal cancer was evaluated by odds ratios (ORs) and 95% confidence intervals (CIs) estimated in the conditional logistic model. The ORs were computed according to tertiles of assayed substances among controls by sex. ORs were further adjusted for potential confounders such as serum total cholesterol, body mass index (BMI), walking habits in daily life, and history of diabetes mellitus. Linear trends of ORs were examined using the medians of tertiles in the conditional logistic model. Calculations were conducted using SAS ® software (SAS Institute, Cary, NC) in the Academic Center for Computing and Media Studies, Kyoto University.
Individual written or oral consent, or consent from community representatives, was obtained, or a poster notification/opting-out system was applied. 8 The Ethical Boards of Nagoya University School of Medicine and Fujita Health University approved this study.
The mean standard deviation ages at baseline were 60.8 8.4 years of age in male cancer cases, 60.0 8.4 years in male controls, 61.1 7.4 years in female cancer cases, and 60.7 7.1 years in female controls. The distributions of serum glycoalbumin and total cholesterol concentrations, as well as BMI, are shown in Table 1 . The mean concentrations of those substances did not differ between cases and controls. The distributions of walking habits in daily life and history of diabetes mellitus are shown in Table 2 . Table 3 shows the ORs and 95% CIs of colorectal cancer adjusted for matching variables -sex, age, and study area. High levels of glycoalbumin showed a trend towards association with an increased risk of colorectal cancer in men (OR = 2.39, p=0.081 The general aspects of the study population, procedures for conducting the baseline survey using a self-administered questionnaire, collecting serum samples, and following-up in the JACC study have been described previously. 8 Diagnosis of colorectal cancer was defined by codes C18, C19, and C20, in the International Statistical Classification of Diseases and Related Health Problems, 10th Revision. 9 Subjects were followed until the end of 1999 for death in all 45 study areas and until the end of 1997 for incidence in the 24 study areas in which incident cases were surveyed using a cancer registry, but follow-up was censored earlier in some areas.
We identified 220 incidents or deaths from colorectal cancer in the study subjects who donated serum samples, who did not have colorectal cancer and who were not being treated for diabetes mellitus at the time of the baseline survey. For each of these 220 patients, we randomly selected two or three control individuals, matched for study area, sex and age, from the study subjects who remained alive and cancer free (602 controls). We could not measure serum glycoalbumin in all eligible cases and controls due to a lack of sufficient volume of serum from some of the subjects. Consequently, glycoalbumin was measured in 117 cases and 263 controls (samples from 51 subjects who died from colon cancer originated from all study areas and samples from 91 who died from or were diagnosed with colorectal cancer were from the 24 above-described study areas). The procedure used in this study to select the measured samples for glycoalbumin among primarily detected cases of colorectal cancer was not as stringent as that used in regular epidemiological studies, and the statistical power was limited by an insufficient number of samples, limiting the interpretation of the results of this analysis.
Serum concentrations of glycoalbumin were determined in 2003 using autoanalyzers (JCA-BM12, JEOL Ltd., Akishima,
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Glycoalbumin concentration is thought to reflect the average blood glucose concentration in the previous 1 to 2 weeks (half life=approximately 14 days), whereas glycohemoglobin A1C (HbA1C) concentration is thought to reflect average blood glucose concentration during the previous 2 to 3 months (half life=120 days). 10 Although an indicator that reflects long-term status is better for epidemiological studies, we assayed glycoalbumin because only serum samples were stored in the JACC Study.
Many epidemiologic studies have found an association between glucose intolerance and increased risk of colorectal cancer. [1] [2] [3] [4] [5] [6] [7] Insulin is thought to influence colorectal carcinogenesis through for the highest tertile). The association seemed to be stronger for cancer of the colon than of the rectum, although both sites had a similar tendency. In contrast, high levels of glycoalbumin showed a trend towards association with a decreased risk of colorectal cancer in women (OR = 0.41, p=0.060 for the highest tertile). This tendency was similar for both colon and rectal cancer. Classified analyses by incidence of colon cancer and colon cancer deaths showed similar results (data not shown).
Adjusting for total cholesterol, BMI, or walking habits in daily life did not substantially change the OR in either sex. Adjusting for history of diabetes mellitus slightly enhanced the association between glycoalbumin level and risk of colorectal cancer (OR = 0.39; 95% CI, 0.15-1.02) in females, but had little effect in males. An insulin-associated decrease in IGFBP-1 and resultant increase in free IGF-1 may increase the risk of colorectal cancer. 1, 6 Thus, carcinogenesis is considered to be promoted by hyperinsulinemia. Glucose intolerance is not necessarily accompanied by hyperinsulinemia. However, it has been reported that elevated glucose or HbA1C levels were associated with colon cancer risk in Western countries. 2, 3, 6, 7 Hence we examined the association between glucose intolerance and colorectal cancer in Japanese people.
In this study, a high level of glycoalbumin was associated with an increased risk of colorectal cancer in men. The association with rectal cancer, however, was weak. These results appear to be in accord with the previous finding that glucose intolerance was more strongly associated with colon than with rectal cancer (the OR for the highest HbA1C quartile relative to the lowest was 2.10 for proximal colon, 1.61 for distal colon, and 0.91 for rectum). 6 Although a previous study has reported that a high blood glucose level increased the risk of colorectal cancer in women (RR = 1.98 for 8.0+ mM in non-fasting individuals) and an insignificant relative risk was shown in men (RR = 0.98), 3 our study detected apparently diverse effects between sexes and a reduced risk for colon cancer in women with glucose intolerance.
The analysis of the whole cohort of the JACC Study indicated that a history of diabetes mellitus significantly increased the risk of colorectal cancer death in women (RR =1.70, 95% CI; 1.03-2.82), but did not increase the risk in men (RR = 0.85, 95% CI; 0.51-1.42) (unpublished data). As for the risk of colorectal cancer incidencce, RR = 1.19 (95% CI; 0.68-2.07) in men, and RR = 1.65 (95% CI; 0.88-3.10) in women. These findings are not consistent with the result of the present study; rather they are consistent with previous reports by other study groups. 2, 3, 6, 7 This inconsistency may be due to inadequate sample selection procedures and insufficient statistical power in the present work.
Adjustment for potential confounders, including serum total cholesterol, BMI, walking habits, and history of diabetes mellitus, had a minimal effect on our results.
In conclusion, a high level of glycoalbumin may increase the risk of colorectal cancer in men. The interpretation of the results was, however, limited by procedural inadequacies and insufficient statistical power.
